Anti-inflammatory effect of thalidomide in paraquat-induced pulmonary injury in mice

International Immunopharmacology

Volumn 17, Issue 2, 2013, Pages 210-215

  Amirshahrokhi, Keyvan ^a  

^a ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokines; Lung injury; Nitric oxide; Paraquat; Thalidomide

Indexed keywords

HYDROXYPROLINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; NITRIC OXIDE; PARAQUAT; THALIDOMIDE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFIBROTIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; HISTOPATHOLOGY; LUNG INJURY; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT DURATION;

CYTOKINES; LUNG INJURY; NITRIC OXIDE; PARAQUAT; THALIDOMIDE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYTOKINES; HYDROXYPROLINE; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; LUNG; LUNG INJURY; MALE; MICE; NITRIC OXIDE; OXIDATIVE STRESS; PARAQUAT; PEROXIDASE; THALIDOMIDE;

EID: 84881495561     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.06.005     Document Type: Article

References (27)

1. Gawarammana IB, Buckley NA. Medical management of paraquat ingestion. Br J Clin Pharmacol 2011;72:745-57.
2. Stephens BG, Moormeister SK. Homicidal poisoning by paraquat. Am J Forensic Med Pathol 1997;18:33-9. (Pubitemid 27147306)
3. He X, Wang L, Szklarz G, Bi Y, Ma Q. Resveratrol inhibits paraquat-induced oxidative stress and fibrogenic response by activating the nuclear factor erythroid 2-related factor 2 pathway. J Pharmacol Exp Ther 2012;342:81-90.
4. Göcgeldi E, Uysal B, Korkmaz A, Ogur R, Reiter RJ, Kurt B, et al. Establishing the use of melatonin as an adjuvant therapeutic against paraquat-induced lung toxicity in rats. Exp Biol Med (Maywood) 2008;233:1133-41.
5. Ishida Y, Takayasu T, Kimura A, Hayashi T, Kakimoto N, Miyashita T, et al. Gene expression of cytokines and growth factors in the lungs after paraquat administration in mice. Leg Med 2006;8:102-9. (Pubitemid 43243310)
6. Morán JM, Ortiz-Ortiz MA, Ruiz-Mesa LM, Fuentes JM. Nitric oxide in paraquat-mediated toxicity: a review. J Biochem Mol Toxicol 2010;24:402-9.
7. Dinis-Oliveira RJ, Duarte JA, Remião F, Sánchez-Navarro A, Bastos ML, Carvalho F. Single high dose dexamethasone treatment decreases the pathological score and increases the survival rate of paraquat-intoxicated rats. Toxicology 2006;227: 73-85. (Pubitemid 44402856)
8. Dinis-Oliveira RJ, Sousa C, Remião F, Duarte JA, Navarro AS, Bastos ML, et al. Full survival of paraquat-exposed rats after treatment with sodium salicylate. Free Radic Biol Med 2007;42:1017-28. (Pubitemid 46356893)
9. Zhao L, Xiao K,Wang H, Wang Z, Sun L, Zhang F, et al. Thalidomide has a therapeutic effect on interstitial lung fibrosis: evidence fromin vitro and in vivo studies. Clin Exp Immunol 2009;157:310-5.
10. Choe JY, Jung HJ, Park KY, Kum YS, Song GG, Hyun DS, et al. Anti-fibrotic effect of thalidomide through inhibiting TGF-beta-induced ERK1/2 pathways in bleomycin-induced lung fibrosis in mice. Inflamm Res 2010;59:177-88.
11. Tabata C, Tabata R, Kadokawa Y, Hisamori S, Takahashi M, Mishima M, et al. Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice. J Immunol 2007;179:708-14. (Pubitemid 46986590)
12. Melchert M, List A. The thalidomide saga. Int J Biochem Cell Biol 2007;39: 1489-99. (Pubitemid 47031027)
13. Amirshahrokhi K, Ghazi-Khansari M. Thalidomide attenuates multiple low-dose streptozotocin-induced diabetes inmice by inhibition of proinflammatory cytokines. Cytokine 2012;60:522-7.
14. Mondello S, Mazzon E, Di Paola R, Crisafulli C, Mondello P, Buemi M, et al. Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model. Shock 2009;32:332-9.
15. Majumder S, Rajaram M, Muley A, Reddy HS, Tamilarasan KP, Kolluru GK, et al. Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase. Br J Pharmacol 2009;158:1720-34.
16. Fattman CL, Chang LY, Termin TA, Petersen L, Enghild JJ, Oury TD. Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic Biol Med 2003;35:763-71. (Pubitemid 37329479)
17. Murrell GA, Tang G, Appleyard RC, del Soldato P, Wang MX. Addition of nitric oxide through nitric oxide-paracetamol enhances healing rat Achilles tendon. Clin Orthop Relat Res 2008;466:1618-24.
18. Amirshahrokhi K, Bohlooli S. Effect of methylsulfonylmethane on paraquat-induced acute lung and liver injury in mice. Inflammation 2013;18.
19. Cho SC, Rhim JH, Choi HR, Son YH, Lee SJ, Song KY, et al. Protective effect of 4,4?-diaminodiphenylsulfone against paraquat-induced mouse lung injury. Exp Mol Med 2011;43:525-37.
20. Kovacs EJ, DiPietro LA. Fibrogenic cytokines and connective tissue production. FASEB J 1994;8:854-61. (Pubitemid 24268877)
21. Berisha HI, Pakbaz H, Absood A, Said SI. Nitric oxide as a mediator of oxidant lung injury due to paraquat. Proc Natl Acad Sci U S A 1994;91:7445-9. (Pubitemid 24238200)
22. Mustafa A, Gado AM, Al-Shabanah OA, Al-Bekairi AM. Protective effect of aminoguanidine against paraquat-induced oxidative stress in the lung of mice. Comp Biochem Physiol C Toxicol Pharmacol 2002;132:391-7. (Pubitemid 34879843)
23. Malleo G, Mazzon E, Genovese T, Di Paola R, Muià C, Crisafulli C, et al. Effects of thalidomide in a mouse model of cerulein-induced acute pancreatitis. Shock 2008;29:89-97.
24. Li D, Xu LY, Chang ZJ, Zhao GJ, Nan C, Lu ZQ. Effect of thalidomide in a mouse model of paraquat-induced acute lung injury and the underlying mechanisms. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2013;31:178-83.
25. Shimazawa R, Sano H, Tanatani A, Miyachi H, Hashimoto Y. Thalidomide as a nitric oxide synthase inhibitor and its structural development. Chem Pharm Bull (Tokyo) 2004;52:498-9. (Pubitemid 41694747)
26. Amirshahrokhi K, Bohlooli S, Chinifroush MM. The effect of methylsulfonylmethane on the experimental colitis in the rat. Toxicol Appl Pharmacol 2011;253: 197-202.
27. Maria de Souza C, Fonseca de Carvalho L, da Silva Vieira T, Candida Araújo E Silva A, Teresa Paz Lopes M, Alves Neves Diniz Ferreira M, et al. Thalidomide attenuates mammary cancer associated-inflammation, angiogenesis and tumor growth in mice. Biomed Pharmacother 2012;66:491-8.